Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
CLOV logo CLOV
Upturn stock ratingUpturn stock rating
CLOV logo

Clover Health Investments Corp (CLOV)

Upturn stock ratingUpturn stock rating
$2.69
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

09/02/2025: CLOV (5-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Outstanding Performance

These Stocks/ETFs, based on Upturn Advisory, have historically outperformed the market, making them a top-tier choice for investors.

Number of Analysts

rating

4 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $3.65

1 Year Target Price $3.65

Analysts Price Target For last 52 week
$3.65 Target price
52w Low $2.12
Current$2.69
52w High $4.87

Analysis of Past Performance

Type Stock
Historic Profit 226.47%
Avg. Invested days 39
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 5.0
Stock Returns Performance Upturn Returns Performance 5.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 09/02/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 1.34B USD
Price to earnings Ratio -
1Y Target Price 3.65
Price to earnings Ratio -
1Y Target Price 3.65
Volume (30-day avg) 4
Beta 1.92
52 Weeks Range 2.12 - 4.87
Updated Date 09/2/2025
52 Weeks Range 2.12 - 4.87
Updated Date 09/2/2025
Dividends yield (FY) -
Basic EPS (TTM) -0.08

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date 2025-08-04
When Before Market
Estimate -0.0187
Actual 0.0329

Profitability

Profit Margin -2.68%
Operating Margin (TTM) -2.21%

Management Effectiveness

Return on Assets (TTM) -4.26%
Return on Equity (TTM) -12.59%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 1013396883
Price to Sales(TTM) 0.84
Enterprise Value 1013396883
Price to Sales(TTM) 0.84
Enterprise Value to Revenue 0.63
Enterprise Value to EBITDA -0.65
Shares Outstanding 420139008
Shares Floating 400287678
Shares Outstanding 420139008
Shares Floating 400287678
Percent Insiders 3.88
Percent Institutions 35.16

ai summary icon Upturn AI SWOT

Clover Health Investments Corp

stock logo

Company Overview

overview logo History and Background

Clover Health Investments Corp. was founded in 2014. It went public in 2021 via a SPAC merger with Social Capital Hedosophia Holdings Corp. III. Clover Health aims to use its Clover Assistant platform to improve healthcare outcomes for Medicare Advantage members.

business area logo Core Business Areas

  • Medicare Advantage Plans: Clover Health offers Medicare Advantage plans to eligible beneficiaries. These plans provide comprehensive healthcare coverage, including medical, hospital, and prescription drug benefits.
  • Clover Assistant: Clover Assistant is a software platform designed to provide physicians with real-time data and insights at the point of care. It helps doctors make more informed decisions, manage patient care more effectively, and improve overall health outcomes.

leadership logo Leadership and Structure

Andrew Toy is the Chief Executive Officer. The company has a board of directors overseeing strategic direction and governance.

Top Products and Market Share

overview logo Key Offerings

  • Medicare Advantage Plans: Clover Health's core product is its Medicare Advantage plans. These plans are offered to eligible Medicare beneficiaries. Market share data for specific regions fluctuates and is dependent on competition. Competitors include UnitedHealth Group (UNH), Humana (HUM), and CVS Health (CVS).
  • Clover Assistant: Clover Assistant is a SaaS platform. While it does generate revenue, its primary value is in improving healthcare outcomes and efficiency within the Clover Health ecosystem. Precise revenue figures are difficult to extract as it's integral to the MA business. Competitors are the other AI-driven software platforms by its main competitors.

Market Dynamics

industry overview logo Industry Overview

The healthcare industry, particularly the Medicare Advantage market, is experiencing growth due to the aging population and increasing demand for value-based care. It is also highly competitive with a lot of regulatory oversight.

Positioning

Clover Health aims to differentiate itself by leveraging technology, specifically the Clover Assistant, to improve care coordination and reduce costs. Its competitive advantage lies in its data-driven approach and focus on physician enablement.

Total Addressable Market (TAM)

The TAM for Medicare Advantage is significant, projected to be in the hundreds of billions of dollars. Clover Health is positioned to capture a share of this market through its technology-driven approach and focus on underserved populations.

Upturn SWOT Analysis

Strengths

  • Proprietary technology (Clover Assistant)
  • Focus on data-driven healthcare
  • Growth in membership
  • Focus on value-based care

Weaknesses

  • High medical costs
  • Dependence on government regulations
  • Relatively small market share compared to larger competitors
  • History of negative profitability

Opportunities

  • Expansion into new geographic markets
  • Increased adoption of Clover Assistant by physicians
  • Partnerships with healthcare providers
  • Further penetration of the Medicare Advantage market

Threats

  • Increased competition from larger, established players
  • Changes in government regulations affecting Medicare Advantage
  • Rising healthcare costs
  • Adverse selection in risk pools

Competitors and Market Share

competitor logo Key Competitors

  • UNH
  • HUM
  • CVS

Competitive Landscape

Clover Health competes with larger, well-established players in the Medicare Advantage market. Its advantage lies in its technology and focus on physician enablement, but it faces challenges in scaling and achieving profitability.

Growth Trajectory and Initiatives

Historical Growth: Clover Health has experienced significant membership growth but has faced challenges with profitability.

Future Projections: Future growth is expected to be driven by increased adoption of Medicare Advantage plans and expansion into new markets. Analyst estimates vary widely based on the company's ability to achieve profitability.

Recent Initiatives: Recent initiatives include expanding Clover Assistant functionality, improving care coordination, and focusing on cost management.

Summary

Clover Health is a growth-oriented company seeking to disrupt the Medicare Advantage market with its technology platform. While it has shown impressive membership growth, it is struggling to become profitable. The company will need to efficiently manage medical costs and differentiate itself from competitors to thrive.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • SEC filings
  • Investor presentations
  • Analyst reports
  • Company press releases

Disclaimers:

The information provided is for informational purposes only and should not be considered investment advice. Market share data is approximate and may vary based on source and methodology. Financial data is based on publicly available information and may not be exhaustive.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Clover Health Investments Corp

Exchange NASDAQ
Headquaters Wilmington, DE, United States
IPO Launch date 2001-01-02
Co-Founder, CEO & Director Mr. Andrew Toy
Sector Healthcare
Industry Healthcare Plans
Full time employees 570
Full time employees 570

Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It operates Clover Assistant, a software platform to execute strategy by enabling physicians to detect, identify, and manage chronic diseases earlier than they otherwise could. The company is based in Wilmington, Delaware.